Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

First blood treatment system in US could cut cost of transfusions

It is difficult to say how much of a role panic over this summer’s Ebola outbreak played in the FDA’s decision to approve Cerus’s blood filtration system, but it seems likely to have...

Upcoming events: Roche PD-L1 data and FDA decisions for AbbVie and Actavis

Welcome to your weekly digest of approaching regulatory and clinical readouts. AbbVie is to receive a US decision imminently on its all oral, interferon-free, hep C combo; the company's US...

BI's Pradaxa available on the NHS for blood clots

BI's Pradaxa available on the NHS for blood clots

Philips buys Volcano and hopes it will not get burned

Is that it for 2014? Or will this remarkable year see another medtech megamerger before midnight on New Year’s Eve? That Philips spending $1.2bn on vascular imaging company Volcano is only...

Auspex drug on target in Ph III Huntington's trial

Auspex drug on target in Ph III Huntington's trial

Pfizer's Inlyta close to approval for NHS use

Pfizer's Inlyta close to approval for NHS use

Janssen launches HIV combo Rezolsta in UK

Janssen launches HIV combo Rezolsta in UK

EMA says much more info needed on Ebola meds

EMA says much more info needed on Ebola meds

FDA gives green light to Novartis acromegaly drug

FDA gives green light to Novartis acromegaly drug

NHS cost watchdog in favour of Bayer's Xofigo

NHS cost watchdog in favour of Bayer's Xofigo
more news